Skip to main content

Table 2 Characteristics of Ta bladder cancer in each group

From: Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor

 

No (n = 704)

Early (n = 208)

Late (n = 155)

p value

Previous TURB

 0

478 (67.9)

115 (55.3)

95 (61.3)

0.01

 1—2

186 (26.4)

72 (34.6)

49 (31.6)

 

  ≥ 3

40 (5.7)

21 (10.1)

11 (7.1)

 

Number of mass

 1

310 (46.0)

65 (32.7)

57 (37.7)

 < 0.001

 2—7

268 (39.8)

81 (40.7)

65 (43.0)

 

  ≥ 8

96 (14.2)

53 (26.6)

29 (19.2)

 

Mass size

  < 3 cm

536 (79.3)

155 (76.7)

123 (80.9)

0.607

  >  = 3 cm

140 (20.7)

47 (23.3)

29 (19.1)

 

Tumor location

 Trigone

162 (23.0)

60 (28.8)

41 (26.5)

0.196

 Posterior wall

195 (27.7)

87 (41.8)

51 (32.9)

0.001

 Both lateral

416 (59.1)

144 (69.2)

91 (58.7)

0.025

 Anterior

143 (20.3)

53 (25.5)

37 (23.9)

0.229

 Dome

144 (20.5)

37 (17.8)

29 (18.7)

0.66

 Prostatic urethra

27 (3.8)

10 (4.8)

6 (3.9)

0.817

Tumor shape

 Papillary

629 (93.5)

178 (88.1)

143 (94.1)

0.03

 Sessile/Flat erythematous

44 (6.5)

24 (11.9)

9 (5.9)

 

Resection depth

 Submucosa

15 (2.2)

4 (2.0)

10 (6.5)

0.039

 Muscle

676 (97.5)

198 (97.5)

142 (92.8)

 

 Perivesical fat

2 (0.3)

1 (0.5)

1 (0.7)

 

Complete TURB

 No

9 (1.3)

10 (4.9)

4 (2.6)

0.009

 Yes

683 (98.7)

196 (95.1)

150 (97.4)

 

Grade

 Low grade

329 (46.7)

99 (47.6)

95 (61.3)

0.004

 High grade

375 (53.3)

109 (52.4)

60 (38.7)

 

 Concomitant CIS

40 (5.7)

16 (7.7)

5 (3.2)

0.188